18 research outputs found
Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer
Full text linkThe role of radiation therapy in the multidisciplinary management of recurrent and metastatic breast cancer
Full text linkDevelopment and first assessment of a RGBW-LED diaphanoscope
Get PDFBackground: Diaphanoscopy is an old but still useful technique in ophthalmic diagnostics. Its application suffers somewhat from the fact that the light is strongly attenuated and red-shifted in color when the eye wall is transilluminated.
Material and methods: A color adjustable diaphanoscope prototype is developed based on a powerful red-green-blue-white light-emitting diode (RGBW-LED). Its optical and thermal properties are measured and tested on the porcine eyes of a local butcher. In addition, based on the technical data, the assumed retinal hazard to human eyes is assessed according to the standard DIN EN ISO 15004-2: 2007-6.
Results: The investigated porcine eyes were brightly illuminated with all LED colors. The calculated values for judging the thermal and photochemical hazard were below the limits given in DIN EN ISO 15004-2: 2007-6.
Conclusion: Based on the standard mentioned above, there is no recognizable danger to the human retina when applied for a limited time, and at least in the porcine model, the presented RGBW-LED diaphanoscope allows an adjustable ophthalmological transillumination without the requirement of the more elaborated devices that are usually employed in operating rooms
Short-Term Intraocular Pressure Rise during Locally Induced Force by Ophthalmologic Surgery Applications
No full textPressure dependent direct transtissue transmission of eyewall, sclera and vitreous body in the range of 350–1050 nm
No full text
Ärztliches "Sich Zeit nehmen" befürwortet – erste Ergebnisse der WAVES-Studie im Rahmen der Diagnosemitteilung Brustkrebs [Abstract]
No full textErste Ergebnisse der WAVES-Studie bestätigen die Annahme einer deutlich höheren Zufriedenheit von Patient:innen im Zusammenhang mit der Mitteilung der Erstdiagnose Brustkrebs, wenn sich die Ärztin / der Arzt Zeit dafür nahm, im Idealfall mindestens 30 Minuten. Der Bedarf an verbesserter Kommunikation hinsichtlich eines angemessenen Zeitrahmens für die Diagnoseübermittlung bei Brustkrebs-Erkrankten wird damit klar aufgezeigt. Diese Daten bieten die Grundlage für eine mögliche Umstrukturierung in der Behandlung Brustkrebs-Erkrankter, die bisher in der aktuellen Vergütungsstruktur nicht abgebildet ist. Die Studie rekrutiert weiterhin
Induction chemotherapy (IC) docetaxel (T), cisplatin (P), 5-fluorouracil (F) (TPF), or TP followed by concomitant boost radiotherapy (R) with or without cetuximab (E) for functional organ preservation (FOP) of resectable laryngeal and hypopharyngeal cancer (LHSCC): First results of the phase II randomized DeLOS-II study.
No full textFinal results of the randomized phase II DeLOS-II trial: Induction chemotherapy (IC) followed by radiotherapy (R) vs. cetuximab (E) plus IC and R for functional larynx preservation in resectable laryngeal and hypopharyngeal cancer (LHSCC).
No full text
